A detailed history of Cadence Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cadence Bank holds 171,799 shares of BMY stock, worth $9.89 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
171,799
Previous 169,118 1.59%
Holding current value
$9.89 Million
Previous $7.02 Million 26.58%
% of portfolio
0.61%
Previous 0.53%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $106,328 - $138,741
2,681 Added 1.59%
171,799 $8.89 Million
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $159,349 - $209,787
3,959 Added 2.4%
169,118 $7.02 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $13,914 - $15,776
290 Added 0.18%
165,159 $8.96 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $2.18 Million - $2.61 Million
45,053 Added 37.6%
164,869 $8.46 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $71,436 - $79,876
1,234 Added 1.04%
119,816 $6.95 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $57,976 - $64,373
910 Added 0.77%
118,582 $7.58 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $42,514 - $48,220
647 Added 0.55%
117,672 $8.16 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $135,453 - $160,396
1,978 Added 1.72%
117,025 $8.42 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $1,109 - $656,059
8,538 Added 8.02%
115,047 $8.18 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $168,187 - $185,233
-2,316 Reduced 2.13%
106,509 $8.2 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $36,949 - $44,305
601 Added 0.56%
108,825 $7.95 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $157,833 - $183,996
2,943 Added 2.8%
108,224 $6.75 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $168,101 - $196,909
2,841 Added 2.77%
105,281 $6.23 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $459,557 - $500,458
-7,423 Reduced 6.76%
102,440 $6.85 Million
Q1 2021

May 11, 2021

BUY
$59.34 - $66.74 $178,910 - $201,221
3,015 Added 2.82%
109,863 $6.94 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $616,894 - $699,054
10,684 Added 11.11%
106,848 $6.63 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $291,399 - $322,909
5,074 Added 5.57%
96,164 $5.8 Million
Q2 2020

Jul 27, 2020

BUY
$54.82 - $64.09 $1,863 - $2,179
34 Added 0.04%
91,090 $5.36 Million
Q1 2020

Apr 30, 2020

BUY
$46.4 - $67.43 $101,012 - $146,795
2,177 Added 2.45%
91,056 $5.08 Million
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $10,580 - $13,800
215 Added 0.24%
88,879 $5.71 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $105,898 - $125,557
2,476 Added 2.87%
88,664 $4.5 Million
Q2 2019

Jul 30, 2019

BUY
$44.62 - $49.34 $1.39 Million - $1.54 Million
31,200 Added 56.74%
86,188 $3.91 Million
Q1 2019

May 02, 2019

BUY
$45.12 - $53.8 $2,165 - $2,582
48 Added 0.09%
54,988 $2.62 Million
Q4 2018

Feb 07, 2019

BUY
$48.76 - $63.23 $2.38 Million - $3.09 Million
48,863 Added 804.06%
54,940 $2.86 Million
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $52,596 - $59,324
-953 Reduced 13.56%
6,077 $377,000
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $6,711 - $7,725
-112 Reduced 1.57%
7,030 $445,000
Q4 2017

Feb 12, 2018

BUY
$59.94 - $65.35 $428,091 - $466,729
7,142
7,142 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cadence Bank Portfolio

Follow Cadence Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.